NCT07342348 Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy
| NCT ID | NCT07342348 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Grand Valley State University |
| Condition | Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-01-19 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2026-01-19 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Approximately 40% of children with ambulatory cerebral palsy have significant functional asymmetries in arm and hand function. Children with these significant functional asymmetries have difficulties using their more-affected (less preferred) arm and hand in daily activities, especially true in daily activities requiring bilateral hand and arm use. Recent research suggests that power mobility training provided via a ride-on toy may help to motivate these children to use their less preferred arm and hand. This research further notes that participation in power mobility training designed to encourage a child to use their less preferred arm and hand also may help to improve their arm and hand function and use in their daily activities. This exploratory study seeks to explore an innovative intervention using arm- and hand-use focused power mobility training activities, encompassing both navigational/maneuvering activities and embedded play-based reaching and grasping activities. During power mobility training activities, children will be asked to wear a soft mitten or sock on their preferred hand to help them remember to use their less preferred hand and arm. The purpose of this exploratory study is to examine both the effect and feasibility of a 6-week laboratory-based arm-and hand-use focused power mobility training program.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of cerebral palsy * Demonstrates significantly less functional use of one arm and hand * Can get on and off the a ride-on toy with minimal assistance from the researchers * Can maintain a sitting position on the a ride-on toy * Has sufficient functional vision to safely maneuver the a ride-on toy * Has their own bicycle helmet that fits them well and is in good working condition Exclusion Criteria: * Hand or arm surgery within the past 6 months * Their weight exceeds device limits (more than 120 pounds) * They do not demonstrate sufficient balance and control in sitting to safely use the ride-on toy * If they cannot safely participate in arm- and hand-use focused power mobility training activities.
Contact & Investigator
Lisa K. Kenyon, PT, DPT, PhD, PCS
PRINCIPAL INVESTIGATOR
Grand Valley State University
Frequently Asked Questions
Who can join the NCT07342348 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 8 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07342348 currently recruiting?
Yes, NCT07342348 is actively recruiting participants. Contact the research team at kenyonli@gvsu.edu for enrollment information.
Where is the NCT07342348 trial being conducted?
This trial is being conducted at Grand Rapids, United States.
Who is sponsoring the NCT07342348 clinical trial?
NCT07342348 is sponsored by Grand Valley State University. The principal investigator is Lisa K. Kenyon, PT, DPT, PhD, PCS at Grand Valley State University. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.